About CHF Solutions
CHF Solutions is a company based in Brooklyn (United States) founded in 1999 was acquired by Gambro in January 2010. CHF Solutions has raised $22.9 million across 1 funding round from investors including Gambro, Turmeric Acquisition Corp and Kaiser Permanente Ventures. CHF Solutions operates in a competitive market with competitors including CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
- Headquarter Brooklyn, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chf Solutions, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CHF Solutions
CHF Solutions has successfully raised a total of $22.9M through 1 strategic funding round. The most recent funding activity was a Series B round of $22.9 million completed in January 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CHF Solutions
CHF Solutions has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Gambro, Turmeric Acquisition Corp and Kaiser Permanente Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital fund focused on early-stage healthcare startups
|
Locked | Locked | Locked |
Investor details for CHF Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CHF Solutions
Investment portfolio details for CHF Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CHF Solutions
Detailed financials for CHF Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chf Solutions Comparisons
Peer comparison for CHF Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CHF Solutions
CHF Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Medical devices for heart failure management are developed.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Implantable inter-atrial shunts are developed to treat chronic heart failure.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
Detailed competitors of CHF Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chf Solutions
Complete news archive for CHF Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CHF Solutions
CHF Solutions was founded in 1999 and raised its 1st funding round 6 years after it was founded.
CHF Solutions is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
CHF Solutions is a funded company, having raised a total of $22.9M across 1 funding round to date.
CHF Solutions was founded in 1999 in Brooklyn, United States, focusing on medical devices within the healthcare sector. The Aquadex FlexFlow system is developed as a mechanical pump and filter for ultrafiltration, enabling the removal of salt and water from patients experiencing fluid overload. Components include a console, disposable circuit, and venous catheter suitable for central or peripheral placement. Acquisition by Gambro Inc. occurred in January 2010.
CHF Solutions's top competitors include Sequana Medical, CVRx and Adona Medical.
CHF Solutions has 5 investors. Key investors include Gambro, Turmeric Acquisition Corp, Kaiser Permanente Ventures, Investor Growth Capital, and SV Health Investors.